Calming And Sleeping Products in Russia
Euromonitor International's Calming And Sleeping Products in Russia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 52 | Publication date: Sep 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Table of contents
OTC HEALTHCARE IN RUSSIA : MARKET INSIGHT
EXECUTIVE SUMMARY
DLO crises causes stagnation in the Russian pharmaceutical market
New registration rules lead to cuts in imports
Generics continues to be predominant in Russia
Domestic pharmaceutical giant among the market leaders
Opportunities for growth
KEY TRENDS AND DEVELOPMENTS
Lifestyles improve, although life expectancy remains low
Self-medication
Growth enabled by many mergers and acquisitions
Private label gains ground
Retailer chains record intensive and extensive growth
CITY KEY TRENDS AND DEVELOPMENTS
Moscow
St Petersburg
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 Sales of OTC Healthcare by City: Value 2002-2007
Table 6 Sales of OTC Healthcare by City: % Value Growth 2002-2007
Table 7 OTC Healthcare Company Shares by Value 2003-2007
Table 8 OTC Healthcare Brand Shares by Value 2004-2007
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
Table 13 Forecast Sales of OTC Healthcare by City: Value 2007-2012
Table 14 Forecast Sales of OTC Healthcare by City: % Value Growth 2007-2012
APPENDIX
OTC Registration and Classification
De-listing or De-reimbursement
Advertising
Packaging and Labelling
Vitamins and dietary supplements registration and classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - RUSSIA
AKRIKHIN OAO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Akrikhin OAO: Key Facts
Summary 4 Akrikhin OAO: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Akrikhin OAO: Competitive Position 2007
BERLIN CHEMIE RUSSIA - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Berlin Chemie/ Menarini Group: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Berlin Chemie/Menarini group : Competitive Position 2007
GLAXOSMITHKLINE PLC - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 8 GlaxoSmithKline PLC: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 GlaxoSmithKline PLC: Competitive Position 2007
NOVARTIS AG - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Novartis AG : Key Facts
Summary 11 Novartis AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Novartis AG: Competitive Position 2007
OTECHESTVENNYE LEKARSTVA OAO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Otechestvennye Lekarstva Holding: Key Facts
Summary 14 Otechestvennye Lekarstva Holding: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Otechestvennye Lekarstva Holding: Competitive Position 2007
PHARMSTANDARD GROUP - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Pharmstandard Group: Key Facts
Summary 17 Pharmstandard Group: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 18 Pahrmstandard Group : Production Statistics 2007
COMPETITIVE POSITIONING
Summary 19 Pharmstandard: Competitive Position 2007
RANBAXY LABORATORIES LTD - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 20 Ranbaxy Laboratories limited: Key Facts
Summary 21 Ranbaxy Laboratories limited: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 22 Ranbaxy ZAO: Competitive Position 2007
SANOFI-AVENTIS - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Sanofi-Aventis: Key Facts
Summary 24 Sanofi-Aventis: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 25 Sanofi-Aventis: Competitive Position 2007
STADA ARZNEIMITTEL AG - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Stada Arzneimittel AG: Key Facts
Summary 27 Stada Arzneimittel AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 Stada Arzneimittel AG: Competitive Position 2007
VEROPHARM ZAO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Veropharm OAO: Key Facts
Summary 30 Veropharm OAO: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 31 Veropharm OAO: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 32 Veropharm OAO: Competitive Position 2007
CALMING AND SLEEPING PRODUCTS IN RUSSIA
TRENDS
SECTOR DATA
Table 15 Sales of Calming and Sleeping Products: Value 2002-2007
Table 16 Sales of Calming and Sleeping Products: % Value Growth 2002-2007
Table 17 Calming and Sleeping Products Company Shares by Value 2003-2007
Table 18 Calming and Sleeping Products Brand Shares by Value 2004-2007
Table 19 Forecast Sales of Calming and Sleeping Products: Value 2007-2012
Table 20 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012